Transcript
  • 14/7/2015 Health Reform and Drug Financing. Selected Topics - Health Economics and Drugs Series, No. 006: 3. Affordability and efficiency: 3.1 Therapeutic

    http://apps.who.int/medicinedocs/es/d/Jwhozip33e/5.html 1/1

    Documento completo | Captulo completo | Expandir ndice | Versin HTML imprimible

    Temas & Palabras clave

    Health Reform and Drug Financing. Selected Topics - Health Economics and Drugs Series, No. 006

    (1998; 49 pages) [French] [Spanish]

    ndice de contenido

    Acknowledgements

    Executive summary

    1. Introduction

    2. Financing reforms

    3. Affordability and efficiency

    3.1 Therapeutic efficiency in drug selection and use

    3.2 Cost-control measures

    3.3 Affordability for consumers

    4. Organizational reforms

    Conclusions

    References

    Back Cover

    3.1 Therapeutic efficiency in drug selection and use

    Therapeutic efficiency, which stems from the appropriate choice and use of drugs with proven safety and effectiveness, is key to

    the achievement of pharmaceutical policy objectives and should lead to greater economic efficiencies in the health sector through

    the elimination of waste. However the reverse is not necessarily true.

    Changes in the health sector, including those associated with competition and economic incentives in the private sector, can lead

    to improved flexibility and managerial efficiency, but may also provide economic incentives for irrational prescribing and drug use.

    Any effort to improve the affordability, availability, and quality of drugs - be it in the public or private sector - should be

    accompanied by sustained efforts to improve the rational use of drugs. These measures are varied and include, but are not limited

    to, public and patient education, development of school curricula on rational use, and prescriber training.

    Because the achievement of public health goals requires therapeutic efficiency, it is the responsibility of the government to ensure

    that rational drug use is promoted regardless of the mechanisms selected for financing and providing drugs.

    El Portal de Informacin - Medicamentos Esenciales y Productos de Salud de la OMS fue diseado y es mantenido por la ONG Human Info. ltima actualizacin: le 16 junio 2015

    Portal de Informacin - Medicamentos Esenciales y Productos de SaludUn recurso de la Organizacin Mundial de la Salud

    English Franais EspaolAyuda Conctese / regstrese

    Buscar

    en

    Buscar Bsqueda avanzada

    Mapa del sitio

    Buscar

    Ttulos A-Z

    Temas

    Palabras clave

    Series y Peridicas

    Publicadores

    Autores A-Z

    Regiones

    Pases

    ndice

    Subcolecciones

    Public sub-collections

    Ayuda y servicios

    Contactos

    Preguntas frecuentes

    Empleo

    Sugerencias

    Privacidad

    Mensajes fraudulentos

    Oficinas regionales de laOMS

    Pgina inicial de la OMS

    Sistemas y Servicios deSalud, OMS

    Medicamentos, OMS

    Sitios OMS

    Conectar con la OMS

    RSS

    Youtube

    Twitter

    Facebook

    OMS 2015

    Pgina inicial del Portal

    Buscar

    Ttulos A-Z

    Temas

    Palabras clave

    Series y Peridicas

    Publicadores

    Autores A-Z

    Regiones

    Pases

    ndice

    Subcolecciones

    Public sub-collections


Recommended